Transthoracic protection circuit for implantable medical devices

• US 9,539,435 B2
• Filed: 04/24/2015
• Issued: 01/10/2017
• Est. Priority Date: 09/08/2014
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Rasmussen, Marshall J, Crutchfield, Randolph E, Boone, Mark R, Cabelka, Lonny V, Kuehn, Kevin P, Pape, Forrest C. M.
• Primary Examiner(s): Wieland, Robert N
• Application Number:
  US14/695,887
• Publication Number:
  US 20160067511A1
• Time in Patent Office: 627 Days
• US Class Current: 1/1
• CPC Class Codes: A61N 1/3925 Monitoring; Protecting
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
• CPC Class Codes: A61N 1/3975 Power supply A61N1/378 takes precedence

Abstract

An implantable medical device includes a low-power circuit, a high-power circuit, and a multi-cell power source. The implantable medical device delivers stimulation therapy to cardiac tissue. The cardioversion energy is delivered across through electrodes that are coupled to terminals of the high-power circuit. A protection circuit for protecting the low-voltage circuit components from high voltage pulses includes a first segment coupled to a first of the electrodes and a second segment coupled to a second of the electrodes, the components of the low-voltage circuit being coupled to the transthoracic protection circuit portion, and a reference potential corresponding to a ground potential, wherein the first and second segments of the transthoracic protection circuit portion are coupled to the reference potential in a parallel configuration.

Claims

1. An implantable medical device for delivery of electrical stimulation therapy to a patient, comprising:

a first tissue interface electrode configured for delivery of the therapy to the patient;

a second tissue interface electrode configured for delivery of the therapy to the patient; and

a low power therapy delivery circuit, including;

a first electrode terminal coupled to the first tissue interface electrode;

a second electrode terminal coupled to the second tissue interface electrode;

a transthoracic protection circuit portion having;

a first segment coupled to the first electrode terminal and a second segment coupled to the second electrode terminal;

an unprotected circuit portion of the low power therapy delivery circuit being coupled to the transthoracic protection circuit portion; and

a reference potential corresponding to a ground potential, wherein the first and second segments of the transthoracic protection circuit portion are coupled to the reference potential in a parallel configuration, and wherein a first impedance of the first segment approximates a second impedance of the second segment.

2. The implantable medical device of claim 1, wherein the transthoracic protection circuit portion splits a cumulative voltage across the first and second electrodes such that the cumulative voltage is apportioned between the first segment and the second segment in a ratio that corresponds to a value defined by a ratio of the first impedance to the second impedance.

3. The implantable medical device of claim 1, wherein the cumulative voltage is delivered by an external device that is external to the implantable medical device.

4. The implantable medical device of claim 1, wherein the transthoracic protection circuit portion comprises an output circuit arrayed to define a high side and a low side, the output circuit including four interconnected legs arranged such that,

the high side includes a first leg coupled to the first electrode terminal and a third leg coupled to the first electrode terminal, and

the low side includes a second leg coupled to the second electrode terminal and a fourth leg coupled to the second electrode terminal, wherein the first tissue interface electrode is coupled to the first electrode terminal and the second tissue interface electrode is coupled to the second electrode terminal.

5. The implantable medical device of claim 4, further comprising a high power therapy delivery circuit coupled to the first and second electrode terminals.

6. The implantable medical system of claim 4, wherein each of the four interconnected legs comprises a semiconductor device.

7. The implantable medical system of claim 6, wherein the first and third legs comprise anode gated thyristors (AGT) and the second and fourth legs comprise silicon controlled rectifiers (SCR).

8. The implantable medical device of claim 1, further comprising a third tissue interface electrode coupled to the second segment of the transthoracic protection circuit portion.

9. The implantable medical device of claim 8, wherein the transthoracic protection circuit portion splits a cumulative voltage across the first electrode and the second and third electrodes such that the cumulative voltage is apportioned between the first segment and the second segment in a ratio that corresponds to a value defined by a ratio of the first impedance to the second impedance.

10. The implantable medical device of claim 8, wherein the cumulative voltage is delivered by an external device that is external to the implantable medical device.

11. The implantable medical device of claim 8, wherein at least one component of the second segment is coupled in series with the third electrode but not the second electrode.

12. The implantable medical device of claim 8, further comprising a fourth tissue interface electrode coupled to the second segment of the transthoracic protection circuit portion.

13. The implantable medical device of claim 12, wherein the transthoracic protection circuit portion splits a cumulative voltage across the first electrode and the second, third and fourth electrodes such that the cumulative voltage is apportioned between the first segment and the second segment in a ratio that corresponds to a value defined by a ratio of the first impedance to the second impedance.

14. The implantable medical device of claim 13, wherein the cumulative voltage is delivered by an external device that is external to the implantable medical device.

15. The implantable medical device of claim 1, wherein the first impedance is a cumulative impedance of components in the first segment and at least a first component of the first segment is connected to at least a second component of the first segment in one of a series or parallel connection.

16. The implantable medical device of claim 1, wherein the first impedance of the first segment includes a first resistance value and a first reactance value.

17. The implantable medical device of claim 16, wherein the second impedance of the second segment includes a second resistance value that is approximately equal to the first resistance value and a second reactance value that is approximately equal to the first reactance value.

18. The implantable medical device of claim 1, wherein the second impedance is a cumulative impedance of components in the second segment and wherein at least a first component of the second segment is connected to at least a second component of the second segment in one of a series or parallel connection.

19. The implantable medical device of claim 1, further comprising at least a fifth or more tissue interface electrode coupled to one of the first segment or second segment of the transthoracic protection circuit portion.